Agfa HealthCare has announced that it has been chosen to implementation a second phase RIS/PACS program at The First Affiliated Hospital of China Medical University in China.
The selection is a follow-up to a first successful co-operation with Agfa HealthCare for the development and roll-out of the hospital's original RIS/PACS in 2006. The project will support The First Affiliated Hospital's ambitions to bring its facility closer to a fully digital environment.
The new collaboration with Agfa Healthcare, which is planned to kick off in this month, will expand the existing RIS/PACS solution to also service the different image intensive departments outside Radiology, including Trauma and Cardiology. In a final phase, the entire RIS/PACS solution will be integrated with the hospital's Hospital Information System (HIS), allowing the distribution of diagnostic information to all clinical departments within the institution. When completed, the phase two RIS/PACS projects will provide clinicians with a complete overview of available diagnostic data, and an integrated information and remote consultation technology platform, allowing the hospital to improve its medical service and management efficiency.
The First Affiliated Hospital of China Medical University is a general hospital with a history of over 100 years, 1500 beds and a daily average outpatient visit of over 4500 persons. The hospital is an early adopter of Hospital Information Systems (HIS) in China. In 2001 it set up the Laboratory Information System (LIS) and realized the integration with HIS. Its Radiology Department has 16 large digital imaging devices with a daily examination rate of 700 patients.
"We look forward to a long-lasting relationship with The First Affiliated Hospital of China Medical University, as we support its drive to move to a fully digital environment" states Paul Gooden, Agfa HealthCare IT General Manager Asia Pacific. "When completed, this project will be an important showcase for RIS/PACS integration in China, and we are proud to have played our role in this exciting venture."
Researchers uncover key mechanisms of CRISPR gene editing